Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SALVAGE THERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 295 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Manfredi, R
      A cross-sectional survey of HIV genotype mutations conferring resistance to all nonnucleoside reverse transcriptase inhibitors and related features, at the time of failure of antiretroviral therapy in the real world

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Veldkamp, AI; van Heeswijk, RPG; Mulder, JW; Meenhorst, PL; Schreij, G; van der Geest, S; Lange, JMA; Beijnen, JH; Hoetelmans, RMW
      Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Gaziev, D; Lucarelli, G
      Novel approaches to the treatment of chronic graft-versus-host disease

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    4. Jones, S; Klotman, ME
      Impact of genotypic resistance testing on physician selection of antiretroviral therapy

      JOURNAL OF HUMAN VIROLOGY
    5. Stuart, MJ; Chao, NS; Horning, SJ; Wong, RM; Negrin, RS; Johnston, LJ; Shizuru, JA; Long, GD; Blume, KG; Stockerl-Goldstein, KE; Goldstein, S
      Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    6. Hanna, GJ; D'Aquila, RT
      Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy

      CLINICAL INFECTIOUS DISEASES
    7. McBride, NC; Cavenagh, JD; Ward, MC; Grant, I; Schey, S; Gray, A; Hughes, A; Mills, MJ; Cervi, P; Newland, AC; Kelsey, SM
      Liposomal daunorubicin (daunoxome) in combination with cyclophosphamide, vincristine and prednisolone (COPA) as salvage therapy in poor-prognosis non-Hodgkins lymphoma

      LEUKEMIA & LYMPHOMA
    8. Stein, RS; Greer, JP; Goodman, S; Brandt, SJ; Morgan, DS; Macon, WR; McCurley, TL; Wolff, SN
      Is total body irradiation a necessary component of preparative therapy forautologous transplantation in non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    9. Gregory, SA; Vose, J; Modiano, M; Kraemer, K; Rifkin, R; Rubin, A; Menduni, T; Ghalie, R
      Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicin- or mitoxantrone-containing regimen

      LEUKEMIA & LYMPHOMA
    10. Manfredi, R; Chiodo, F
      Switch of protease inhibitor-containing HAART in routine clinical practice: a four-year prospective observational study

      INTERNATIONAL JOURNAL OF STD & AIDS
    11. Maggiolo, F
      Comparison of NNRTIs in antiretroviral-experienced patients

      INTERNATIONAL JOURNAL OF STD & AIDS
    12. Machover, D; Delmas-Marsalet, B; Misra, SC; Gumus, Y; Goldschmidt, E; Schilf, A; Frenoy, N; Emile, JF; Debuire, B; Guettier, C; Farrokhi, P; Boulefdaoui, B; Norol, F; Parquet, N; Ulusakarya, A; Jasmin, C
      Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma

      ANNALS OF ONCOLOGY
    13. Hagemeister, FB; Donato, M
      Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience

      EUROPEAN JOURNAL OF HAEMATOLOGY
    14. Reiser, M; Bredenfeld, H; Engert, A; Diehl, V
      The role of ifosfamide in the treatment of relapsed and refractory lymphoma

      EUROPEAN JOURNAL OF HAEMATOLOGY
    15. Coleman, M; Leonard, J; Shuster, MW; Kaufman, TP
      DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL)

      EUROPEAN JOURNAL OF HAEMATOLOGY
    16. Bonfante, V; Viviani, S; Devizzi, L; Di Russo, A; Di Nicola, M; Magni, M; Matteucci, P; Grisanti, S; Valagussa, P; Bonadonna, G; Gianni, AM
      High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease

      EUROPEAN JOURNAL OF HAEMATOLOGY
    17. Markman, M
      Is there a role for intraperitoneal chemotherapy in the management of ovarian cancer?

      ONCOLOGY-NEW YORK
    18. Kaufmann, GR; Suzuki, K; Cunningham, P; Mukaide, M; Kondo, M; Imai, M; Zaunders, J; Cooper, DA
      Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    19. Penn, ML; Myers, M; Eckstein, DA; Liegler, TJ; Hayden, M; Mammano, F; Clavel, F; Deeks, SG; Grant, RM; Goldsmith, MA
      Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    20. Brechtl, JR; Breitbart, W; Galietta, M; Krivo, S; Rosenfeld, B
      The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: Impact on medical, palliative care, and quality of life outcomes

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    21. Leautez, S; Billaud, E
      The place of saquinavir in the treatment of HIV infected adult in years 2001

      PRESSE MEDICALE
    22. Fizazi, K; Tjulandin, S; Salvioni, R; Germa-Lluch, JR; Bouzy, J; Ragan, D; Bokemeyer, C; Gerl, A; Flechon, A; de Bono, JS; Stenning, S; Horwich, A; Pont, J; Albers, P; De Giorgi, U; Bower, M; Bulanov, A; Pizzocaro, G; Aparicio, J; Nichols, CR; Theodore, C; Hartmann, JT; Schmoll, HJ; Kaye, SB; Culine, S; Droz, JP; Mahe, C
      Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: Prognostic factors and role of postsurgery chemotherapy-results from an international study group

      JOURNAL OF CLINICAL ONCOLOGY
    23. Beyer, J; Rick, O; Siegert, W; Bokemeyer, C
      Salvage chemotherapy in relapsed germ cell tumors

      WORLD JOURNAL OF UROLOGY
    24. Palumbo, A; Giaccone, L; Bertola, A; Pregno, P; Bringhen, S; Rus, C; Triolo, S; Gallo, E; Pileri, A; Boccadoro, M
      Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma

      HAEMATOLOGICA
    25. Hanel, M; Friedrichsen, K; Hanel, A; Herbst, R; Morgner, A; Neser, S; Nicklisch, M; Teich, M; Ehninger, G; Fiedler, F
      Mito-FLAG as salvage therapy for relapsed and refractory acute myeloid leukemia

      ONKOLOGIE
    26. Ota, S; Sugiyama, T; Komai, K; Hirai, N; Kumagai, S; Ushijima, K; Nishida, T; Kamura, T
      Weekly 1 hour paclitaxel infusion in patients with recurrent gynecologicaltumors: a pilot study

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    27. McDonough, MJ; Feldmeier, JJ; Parsai, I; Dobelbower, RR; Selman, SH
      Salvage external beam radiotherapy for clinical failure after cryosurgery for prostate cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    28. Puthawala, A; Syed, AMN; Gamie, S; Chen, YJ; Londrc, A; Nixon, V
      Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: Long-term results

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    29. Ng, AK; Kuntz, KM; Mauch, PM; Weeks, JC
      Costs and effectiveness of staging and treatment options in early-stage Hodgkin's disease

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    30. Christian, J; Thomas, H
      Ovarian cancer chemotherapy

      CANCER TREATMENT REVIEWS
    31. Brandt, L; Kimby, E; Nygren, P; Glimelius, B
      A systematic overview of chemotherapy effects in Hodgkin's disease

      ACTA ONCOLOGICA
    32. Mocroft, A; Phillips, AN; Miller, V; Gatell, J; van Lunzen, J; Parkin, JM; Weber, R; Roge, B; Lazzarin, A; Lundgren, JD
      The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study

      AIDS
    33. Ratanatharathorn, V; Ayash, L; Lazarus, HM; Fu, J; Uberti, JP
      Chronic graft-versus-host disease: clinical manifestation and therapy

      BONE MARROW TRANSPLANTATION
    34. Ayash, LJ; Clarke, M; Silver, SM; Braun, T; Uberti, J; Ratanatharathorn, V; Reynolds, C; Ferrara, J; Broun, ER; Adams, PT
      Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review

      BONE MARROW TRANSPLANTATION
    35. Lazarus, HM; Loberiza, FR; Zhang, MJ; Armitage, JO; Ballen, KK; Bashey, A; Bolwell, BJ; Burns, LJ; Freytes, CO; Galeg, RP; Gibson, J; Herzig, RH; LeMaistre, CF; Marks, D; Mason, J; Miller, AM; Milone, GA; Pavlovsky, S; Reece, DE; Rizzo, JD; van Besien, K; Vose, JM; Horowitz, MM
      Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)

      BONE MARROW TRANSPLANTATION
    36. Hanel, M; Kroger, N; Kroschinsky, F; Birkmann, J; Hanel, A; Herbst, R; Naumann, R; Friedrichsen, K; Ehninger, G; Zander, AR; Fiedler, F
      Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    37. Giri, J; Rueda, HJ; Monticelli, A; Pirola, DA; Planes, N
      Novel deletion in 67 codon in HIV reverse transcriptase gene in antiretroviral treatment failure.

      MEDICINA-BUENOS AIRES
    38. Teknos, TN; Myers, LL; Bradford, CR; Chepeha, DB
      Free tissue reconstruction of the hypopharynx after organ preservation therapy: Analysis of wound complications

      LARYNGOSCOPE
    39. Simon, JH; Zhen, WN; McCulloch, TM; Hoffman, HT; Paulino, AC; Mayr, NA; Buatti, JM
      Esthesioneuroblastoma: The University of Iowa experience 1978-1998

      LARYNGOSCOPE
    40. Altfeld, MA; Livingston, B; Reshamwala, N; Nguyen, PT; Addo, MM; Shea, A; Newman, M; Fikes, J; Sidney, J; Wentworth, P; Chesnut, R; Eldridge, RL; Rosenberg, ES; Robbins, GK; Brander, C; Sax, PE; Boswell, S; Flynn, T; Buchbinder, S; Goulder, PJR; Walker, BD; Sette, A; Kalams, SA
      Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif

      JOURNAL OF VIROLOGY
    41. Flechon, A; Rivoire, M; Biron, P; Droz, JP
      Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors

      JOURNAL OF UROLOGY
    42. Chin, JL; Pautler, SE; Mouraviev, V; Touma, N; Moore, K; Downey, DB
      Results of salvage cryoablation of the prostate after radiation: Identifying predictors of treatment failure and complications

      JOURNAL OF UROLOGY
    43. Izawa, JI; Perrotte, P; Greene, GF; Scott, S; Levy, L; McGuire, E; Madsen, L; von Eschenbach, AC; Pisters, LL
      Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy

      JOURNAL OF UROLOGY
    44. Perez, EE; Rose, SL; Peyser, B; Lamers, SL; Burkhardt, B; Dunn, BM; Hutson, AD; Sleasman, JW; Goodenow, MM
      Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients

      JOURNAL OF INFECTIOUS DISEASES
    45. Call, SA; Saag, MS; Westfall, AO; Raper, JL; Pham, SV; Tolson, JM; Hellmann, NS; Cloud, GA; Johnson, VA
      Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiencyvirus infection

      JOURNAL OF INFECTIOUS DISEASES
    46. Schild, SE
      Radiation therapy (RT) after prostatectomy: The case for salvage therapy as opposed to adjuvant therapy

      INTERNATIONAL JOURNAL OF CANCER
    47. Baker, VV
      Treatment options for ovarian cancer

      CLINICAL OBSTETRICS AND GYNECOLOGY
    48. Papadimitriou, CA; Kouroussis, C; Moulopoulos, LA; Vlahos, G; Rodolakis, A; Kiamouris, C; Diakomanolis, E; Gika, D; Michalas, S; Dimopoulos, MA
      Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer

      CANCER
    49. Penson, RT; Supko, JG; Seiden, MV; Fuller, AF; Berkowitz, RS; Goodman, A; Campos, SM; MacNeill, KM; Cook, S; Matulonis, UA
      A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Mullerian tumors

      CANCER
    50. Rivoire, M; Elias, D; De Cian, F; Kaemmerlen, P; Theodore, C; Droz, JP
      Multimodality treatment of patients with liver metastases from germ cell tumors - The role of surgery

      CANCER
    51. Flechon, A; Droz, JP
      Is there still indication of high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?

      BULLETIN DU CANCER
    52. Martin, A; Fernandez-Jimenez, MC; Caballero, MD; Canales, MA; Perez-Simon, JA; de Bustos, JG; Vazquez, L; Hernandez-Navarro, F; San Miguel, JF
      Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease

      BRITISH JOURNAL OF HAEMATOLOGY
    53. Marsden, DE; Friedlander, M; Hacker, NF
      Current management of epithelial ovarian carcinoma: A review

      SEMINARS IN SURGICAL ONCOLOGY
    54. Sagae, S; Kudo, R
      Surgery for germ cell tumors

      SEMINARS IN SURGICAL ONCOLOGY
    55. Drachenberg, DE
      Treatment of prostate cancer: Watchful waiting, radical prostatectomy, andcryoablation

      SEMINARS IN SURGICAL ONCOLOGY
    56. Bini, T; Testa, L; Chiesa, E; Adorni, F; Abeli, C; Castelnuovo, B; Melzi, S; Sollima, S; Bongiovanni, M; Monforte, AD
      Outcome of a second-line protease inhibitor-containing regimen in patientsfailing or intolerant of a first highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    57. Shulman, NS; Zolopa, AR; Passaro, DJ; Murlidharan, U; Israelski, DM; Brosgart, CL; Miller, MD; Van Doren, S; Shafer, RW; Katzenstein, DA
      Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: Clinical and genotypic predictors of virologic response

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    58. Farrugia, D; Ansell, W; Singh, M; Philp, T; Chinegwundoh, F; Oliver, RTD
      Stilboestrol plus adrenal suppression as salvage treatment for patients failing treatment with luteinizing hormone-releasing hormone analogues and orchidectomy

      BJU INTERNATIONAL
    59. Walewski, J; Krzyzanowska, JB; Kraszewska, E; Lampka, E; Romejko-Jarosinska, J; Miskiewicz, Z; Meder, J
      CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma

      MEDICAL ONCOLOGY
    60. Carnevale-Schianca, F; Martin, P; Sullivan, K; Flowers, M; Gooley, T; Anasetti, C; Deeg, J; Furlong, T; McSweeney, P; Storb, R; Nash, RA
      Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    61. Radich, JP; Gooley, T; Sanders, JE; Anasetti, C; Chauncey, T; Appelbaum, FR
      Second allogeneic transplantation after failure of first autologous transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    62. Marina, NM; Poquette, CA; Cain, AM; Jones, D; Pratt, CB; Meyer, WH
      Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    63. Ratei, R; Matylis, A; Krahl, D; Arnold, R; Stein, H; Dorken, B; Ludwig, WD
      Salvage therapy for relapsed mediastinal B-cell lymphoma with allogeneic HLA-identical related donor bone marrow transplantation, donor lymphocyte infusion and IDEC-C2B8

      LEUKEMIA & LYMPHOMA
    64. Lorusso, V; Palmieri, G; Bianco, AR; Abate, G; Catalano, G; De Vita, F; Dammacco, F; Lauta, VM; Lucarelli, G; Polimeno, G; Mantovani, G; D'Aprile, M; Marzullo, F; De Lena, M
      CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group

      INTERNATIONAL JOURNAL OF ONCOLOGY
    65. Trope, C; Marth, C; Kaern, J
      Tamoxifen in the treatment of recurrent ovarian carcinoma

      EUROPEAN JOURNAL OF CANCER
    66. Oettle, H; Arnold, D; Esser, M; Huhn, D; Riess, H
      Paclitaxel as weekly second-line therapy in patients with advanced pancreatic carcinoma

      ANTI-CANCER DRUGS
    67. Resch, W; Swanstrom, R
      Protease inhibitor resistance in HIV-1 infection

      REVIEWS IN MEDICAL MICROBIOLOGY
    68. Hanel, M; Kroger, N; Hoffknecht, MM; Peters, SO; Metzner, B; Fiedler, F; Braumann, D; Schubert, JC; Illiger, HJ; Hanel, A; Kruger, WH; Zeller, W; Weh, HJ; Hossfeld, DK; Zander, AR
      ASHAP - an effective salvage therapy for recurrent and refractory malignant lymphomas

      ANNALS OF HEMATOLOGY
    69. Neben, K; Hohaus, S; Goldschmidt, H; Egerer, G; Voso, MT; Ho, AD; Haas, R
      High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors

      ANNALS OF HEMATOLOGY
    70. La Barbera, EO; Chiusolo, P; Laurenti, L; Menichella, G; Di Febo, AL; Piccirillo, N; Sora, F; Marra, R; Teofili, L; Leone, G; Sica, S
      MiCMA: An alternative treatment for refractory or recurrent Hodgkin's disease

      ANNALS OF ONCOLOGY
    71. Miyazaki, J; Miyanaga, N; Kawai, K; Shimazui, T; Takeshima, H; Akaza, H
      High-dose chemotherapy with peripheral blood stem cell transplantation foradvanced testicular cancer

      INTERNATIONAL JOURNAL OF UROLOGY
    72. Estey, EH
      Treatment of relapsed and refractory acute myelogenous leukemia

      LEUKEMIA
    73. Clumeck, N; De Wit, S
      Update on highly active antiretroviral therapy: progress and strategies

      BIOMEDICINE & PHARMACOTHERAPY
    74. Khayat, D; Antoine, EC; Coeffic, D
      Taxol in the management of cancers of the breast and the ovary

      CANCER INVESTIGATION
    75. Porcu, P; Bhatia, S; Sharma, M; Einhorn, LH
      Results of treatment after relapse from high-dose chemotherapy in germ cell tumors

      JOURNAL OF CLINICAL ONCOLOGY
    76. Josting, A; Reiser, M; Rueffer, U; Salzberger, B; Diehl, V; Engert, A
      Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: Is there a chance for cure?

      JOURNAL OF CLINICAL ONCOLOGY
    77. Motzer, RJ; Sheinfeld, J; Mazumdar, M; Bains, M; Mariani, T; Bacik, J; Bajorin, D; Bosl, GJ
      Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer

      JOURNAL OF CLINICAL ONCOLOGY
    78. Clevenbergh, P; Durant, J; Garraffo, R; Chaillou, S; Cua, E; Dellamonica, P
      Multiples aspects of VIH resistance to antiretroviral drugs.

      MEDECINE ET MALADIES INFECTIEUSES
    79. Fujimura, H; Kikkawa, F; Oguchi, H; Nakashima, N; Mizutani, S
      Adjuvant chemotherapy including cisplatin in endometrial carcinoma

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    80. Giles, FJ; Wickham, NR; Rapoport, BL; Somlo, G; Lim, SW; Shan, JQ; Lynott, AM
      Cyclophosphamide, etoposide, vincristine, adriamycin, and dexamethasone (CEVAD) regimen in refractory multiple myeloma: An International Oncology Study Group (IOSG) Phase II protocol

      AMERICAN JOURNAL OF HEMATOLOGY
    81. Perez-Elias, MJ; Lanier, R; Munoz, V; Garcia-Arata, I; Casado, JL; Marti-Belda, P; Moreno, A; Dronda, F; Antela, A; Marco, S; Moreno, S
      Phenotypic testing predicts virological response in successive protease inhibitor-based regimens

      AIDS
    82. Khanna, N; Klimkait, T; Schiffer, V; Irigoyen, J; Telenti, A; Hirschel, B; Battegay, M
      Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients

      AIDS
    83. Miller, V; Sabin, C; Hertogs, K; Bloor, S; Martinez-Picado, J; D'Aquila, R; Larder, B; Lutz, T; Gute, P; Weidmann, E; Rabenau, H; Phillips, A; Staszewski, S
      Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

      AIDS
    84. Izopet, J; Massip, P; Souyris, C; Sandres, K; Puissant, B; Obadia, M; Pasquier, C; Bonnet, E; Marchou, B; Puel, J
      Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen

      AIDS
    85. Mocroft, A; Devereux, H; Kinloch-de-Loes, S; Wilson, D; Madge, S; Youle, M; Tyrer, M; Loveday, C; Phillips, AN; Johnson, MA
      Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population

      AIDS
    86. Cronin, S; Uberti, JP; Ayash, LJ; Raith, C; Ratanatharathorn, V
      Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    87. Stein, RS; Greer, JP; Goodman, S; Brandt, SJ; Morgan, DS; Macon, WR; McCurley, TL; Wolff, SN
      Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma

      BONE MARROW TRANSPLANTATION
    88. Vuky, J; McCaffrey, J; Ginsberg, M; Mariani, T; Bajorin, DF; Bosl, GJ; Motzer, RJ
      Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors

      INVESTIGATIONAL NEW DRUGS
    89. Gordon, MS; Young, ML; Tallman, MS; Cripe, LD; Bennett, JM; Paietta, E; Longo, W; Gerad, H; Mazza, J; Rowe, JM
      Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia - A study of the Eastern Cooperative Oncology Group (ECOG), E5995

      LEUKEMIA RESEARCH
    90. Kushner, BH; Kramer, K; Meyers, PA; Wollner, N; Cheung, NKV
      Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors

      MEDICAL AND PEDIATRIC ONCOLOGY
    91. Korones, DN; Fisher, PG; Cohen, KJ; Dubowy, RL
      No responses to oral etoposide in 15 patients with recurrent brain tumors

      MEDICAL AND PEDIATRIC ONCOLOGY
    92. King, K; Younes, A
      Ifosfamide- and paclitaxel-based treatment of relapsed and refractory lymphoma

      SEMINARS IN ONCOLOGY
    93. Stroyakovsky, DL; Pivnik, AV; Shavlokhov, VS; Sotnikov, VM; Moiseeva, TN; Rasstrigin, NA; Margolin, OV; Efimov, IV; Dzhumabaeva, BT; Kaplanskaya, IB; Roschina, LS
      Pilot results of combined therapy of recurrent and refractory forms of Hodgkin's disease (polychemotherapy, radiotherapy, removal of residual mediastinal mass)

      TERAPEVTICHESKII ARKHIV
    94. Nahleh, Z; Gallardo, J; Tabbara, IA
      Advanced germ cell tumors in male patients

      SOUTHERN MEDICAL JOURNAL
    95. Izawa, JI; Ajam, K; McGuire, E; Scott, S; von Eschenbach, AC; Skibber, J; Pisters, LL
      Major surgery to manage definitively severe complications of salvage cryotherapy for prostate cancer

      JOURNAL OF UROLOGY
    96. Vaidya, A; Soloway, MS
      Salvage radical prostatectomy for radiorecurrent prostate cancer: Morbidity revisited

      JOURNAL OF UROLOGY
    97. Albers, P; Ganz, A; Hannig, E; Miersch, MDE; Muller, SC
      Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers

      JOURNAL OF UROLOGY
    98. Renard, AJ; Veth, RP; Schreuder, HWB; Van Loon, CJ; Koops, HS; Van Horn, JR
      Function and complications after ablative and limb-salvage therapy in lower extremity sarcoma of bone

      JOURNAL OF SURGICAL ONCOLOGY
    99. Peschel, RE; Robnett, TJ; Hesse, D; King, CR; Ennis, RD; Schiff, PB; Wilson, LD
      PSA based review of adjuvant and salvage radiation therapy vs. observationin postoperative prostate cancer patients

      INTERNATIONAL JOURNAL OF CANCER
    100. du Bois, A; Luck, HJ; Bauknecht, T; Pfisterer, J; Meier, W
      Second-line chemotherapie after platinum or platinum and paclitaxel-based chemotherapy for ovarian cancer: A systematic review

      GEBURTSHILFE UND FRAUENHEILKUNDE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 15:59:46